Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 8, Issue 329, Pages 329ra34-329ra34
Publisher
American Association for the Advancement of Science (AAAS)
Online
2016-03-10
DOI
10.1126/scitranslmed.aad5653
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer
- (2015) Samantha Russell et al. FASEB JOURNAL
- Overexpression of Elafin in Ovarian Carcinoma Is Driven by Genomic Gains and Activation of the Nuclear Factor κB Pathway and Is Associated with Poor Overall Survival
- (2015) Adam Clauss et al. NEOPLASIA
- Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
- (2014) Sunila Pradeep et al. CANCER CELL
- Coming into focus: the nonovarian origins of ovarian cancer
- (2013) L. Dubeau et al. ANNALS OF ONCOLOGY
- Bone Marrow–Derived Gr1 + Cells Can Generate a Metastasis-Resistant Microenvironment Via Induced Secretion of Thrombospondin-1
- (2013) Raúl Catena et al. Cancer Discovery
- CD47 functions as a molecular switch for erythrocyte phagocytosis
- (2012) P. Burger et al. BLOOD
- ABT-898 Induces Tumor Regression and Prolongs Survival in a Mouse Model of Epithelial Ovarian Cancer
- (2011) N. Campbell et al. MOLECULAR CANCER THERAPEUTICS
- Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma
- (2009) Joyce F. Liu et al. GYNECOLOGIC ONCOLOGY
- Clinical relevance of extent of extreme drug resistance in epithelial ovarian carcinoma
- (2009) Koji Matsuo et al. GYNECOLOGIC ONCOLOGY
- Low drug resistance to both platinum and taxane chemotherapy on anin vitrodrug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer
- (2009) Koji Matsuo et al. INTERNATIONAL JOURNAL OF CANCER
- ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer
- (2009) J. Greenaway et al. MOLECULAR CANCER THERAPEUTICS
- Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1
- (2009) S.-Y. Kang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ovarian Cancer Pathogenesis: A Model in Evolution
- (2009) Alison M. Karst et al. Journal of Oncology
- Thrombospondin 1 Promotes Tumor Macrophage Recruitment and Enhances Tumor Cell Cytotoxicity of Differentiated U937 Cells
- (2008) G. Martin-Manso et al. CANCER RESEARCH
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now